Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma May 16, 2019
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights May 13, 2019
Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights May 10, 2019
Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights May 10, 2019
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights May 09, 2019
Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein May 08, 2019
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab May 01, 2019
